Profile data is unavailable for this security.
About the company
Hester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.
- Revenue in INR (TTM)3.05bn
- Net income in INR188.89m
- Incorporated1987
- Employees693.00
- LocationHester Biosciences LtdPushpak 1st FloorMotilal Hirabhai Road, Panchvati CircleAHMEDABAD 380006IndiaIND
- Phone+91 7 926445107
- Fax+91 7 926445105
- Websitehttps://www.hester.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syncom Formulations (India) Ltd | 2.63bn | 253.14m | 14.16bn | 799.00 | 44.29 | 4.91 | 47.13 | 5.37 | 0.34 | 0.34 | 3.56 | 3.07 | 0.6732 | 7.42 | 2.95 | -- | 6.47 | 7.50 | 9.00 | 10.23 | 40.44 | 34.59 | 9.61 | 9.38 | 2.38 | 5.57 | 0.201 | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
Windlas Biotech Ltd | 6.31bn | 581.87m | 14.33bn | 1.05k | 24.55 | 3.17 | 20.01 | 2.27 | 27.94 | 27.94 | 302.99 | 216.33 | 1.09 | 5.79 | 4.99 | -- | 10.07 | -- | 13.50 | -- | 37.21 | -- | 9.22 | -- | 2.15 | 58.58 | 0.008 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
Zota Health Care Ltd | 1.80bn | -143.48m | 14.95bn | 338.00 | -- | 16.19 | 260.23 | 8.28 | -5.59 | -5.59 | 70.40 | 34.81 | 0.9341 | 2.02 | 6.55 | -- | -7.42 | -1.38 | -10.54 | -1.85 | 46.43 | 36.48 | -7.95 | -1.33 | 0.7851 | -2.62 | 0.5143 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
Ngl Fine Chem Ltd | 3.39bn | 413.43m | 15.68bn | 343.00 | 37.93 | 5.97 | 29.61 | 4.63 | 66.92 | 66.92 | 548.61 | 425.11 | 1.05 | 4.51 | 4.36 | -- | 12.87 | 15.06 | 16.61 | 19.58 | 53.18 | 46.79 | 12.20 | 13.15 | 1.96 | 30.64 | 0.1218 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
Borosil Scientific Ltd | -100.00bn | -100.00bn | 16.65bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Sigachi Industries Ltd | 3.99bn | 571.80m | 19.06bn | 1.03k | 35.37 | 4.44 | 28.00 | 4.78 | 1.64 | 1.64 | 11.51 | 13.09 | 0.7472 | 3.19 | 3.41 | -- | 10.73 | 14.77 | 14.42 | 19.57 | 51.09 | 50.34 | 14.35 | 14.92 | 1.29 | 8.48 | 0.2552 | -- | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
Themis Medicare Ltd | 3.82bn | 435.24m | 20.22bn | 1.54k | 46.52 | 5.35 | 36.26 | 5.30 | 4.72 | 4.72 | 41.44 | 41.03 | 0.7067 | 1.96 | 2.36 | 2,477,358.00 | 8.06 | 11.12 | 11.07 | 16.46 | 64.19 | 60.32 | 11.40 | 14.96 | 1.44 | -- | 0.2023 | 7.59 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
Amrutanjan Health Care Ltd | 4.21bn | 449.73m | 21.35bn | 575.00 | 47.65 | 7.40 | 41.84 | 5.07 | 15.51 | 15.51 | 145.00 | 99.85 | 1.16 | 7.34 | 10.41 | -- | 12.34 | 16.22 | 15.09 | 20.12 | 49.71 | 53.30 | 10.68 | 13.23 | 3.82 | 291.99 | 0.006 | 23.37 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 21.70bn | 1.10k | 43.53 | 4.05 | 26.89 | 3.06 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
Hester Biosciences Ltd | 3.05bn | 188.89m | 21.91bn | 693.00 | 103.46 | 7.51 | 57.14 | 7.19 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
IOL Chemicals and Pharmaceuticals Ltd. | 21.33bn | 1.34bn | 23.64bn | 2.56k | 17.59 | 1.47 | 11.98 | 1.11 | 22.90 | 22.90 | 363.33 | 274.49 | 0.9998 | 3.72 | 4.37 | -- | 6.30 | 14.91 | 8.27 | 19.45 | 34.50 | 34.79 | 6.30 | 12.00 | 1.24 | 10.41 | 0.0199 | -- | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
Solara Active Pharma Sciences Ltd | 13.26bn | -5.67bn | 24.12bn | 2.36k | -- | 2.41 | -- | 1.82 | -145.25 | -145.25 | 339.41 | 239.08 | 0.505 | 1.75 | 2.99 | -- | -21.60 | -2.44 | -39.08 | -3.84 | 39.28 | 43.38 | -42.77 | -4.49 | 0.3549 | -1.89 | 0.5192 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
Dishman Carbogen Amcis Ltd | 26.16bn | -1.53bn | 24.94bn | 1.30k | -- | 0.4432 | 15.84 | 0.9535 | -9.79 | -9.79 | 166.66 | 358.94 | 0.2748 | 0.7081 | 4.98 | -- | -1.61 | -0.3986 | -2.09 | -0.4888 | 77.17 | 74.89 | -5.87 | -1.54 | 0.4092 | -0.1265 | 0.2913 | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 26.10bn | 1.23k | -- | 82.56 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
Morepen Laboratories Ltd | 16.90bn | 961.60m | 28.19bn | 1.65k | 29.34 | 3.33 | 21.67 | 1.67 | 1.88 | 1.88 | 33.11 | 16.58 | 1.41 | 4.45 | 5.74 | -- | 8.04 | 7.90 | 11.50 | 13.34 | 37.15 | 33.65 | 5.72 | 5.49 | 1.59 | 33.73 | 0.0331 | -- | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
Holder | Shares | % Held |
---|---|---|
Dimensional Fund Advisors LPas of 30 Apr 2024 | 27.97k | 0.33% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 3.28k | 0.04% |
Dimensional Fund Advisors Ltd.as of 31 May 2024 | 333.00 | 0.00% |
DFA Australia Ltd.as of 30 Apr 2024 | 124.00 | 0.00% |
Motilal Oswal Asset Management Co. Ltd.as of 30 Jun 2024 | 54.00 | 0.00% |